Stay updated on NVG-111 in ROR1+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.
Latest updates to the NVG-111 in ROR1+ Malignancies Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated to v3.3.4; the previous revision v3.3.3 was removed.SummaryDifference0.1%
- Check11 days agoChange DetectedAdded a status metadata block showing the last known status (Unknown) for the study, including sponsor NovalGen Ltd. and date 2022-09.SummaryDifference0.4%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter updated to Revision: v3.3.3; the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed.SummaryDifference0.1%
- Check54 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed on the page; no visible changes to study details or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check61 days agoChange DetectedThe page no longer displays the general government operating status notice that informed readers about potential delays and where to find status updates. This notice is unrelated to the trial details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check76 days agoChange DetectedThe page content appears unchanged between screenshots; sections such as Study Overview, Eligibility Criteria, and Contacts remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
Stay in the know with updates to NVG-111 in ROR1+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.